Shanghai, China – On April 1, MicroPort Scientific Corporation ("MPSC") is pleased to announce that effective immediately Mr. Jonathan Chen has been promoted to Chief International Business Officer of MPSC.
Mr. Jonathan Chen joint in MPSC in July of 2012, and originally served as the Executive Vice President of International Operations and Investor Relations of MPSC. He has become the Chairperson of MPSC's Intercontinental Executive Committee ("IEC") since September, 2015. Mr. Chen's primary responsibilities include growing the company's International business in markets outside of China, primarily in the markets of the U.S, Europe and South America.
Mr. Chen has over 21 years of experience in the medical device industry. Prior to joining the company, Mr. Chen worked for Angiotech Pharmaceuticals, Inc. for six years, where he was Senior Vice President of Business Development. Prior to joining Angiotech, Mr. Chen was a life sciences investment banker for Credit Suisse and Alex. Brown & Sons. He advised on over $3 billion in Mergers & Acquisitions transactions.
Mr. Chen has a Bachelor of Arts degree in Economics and a Bachelor of Sciences degree with honors in Biological Sciences from Stanford University.